Neoadjuvant Pembrolizumab + Epacadostat Prior to Curative Surgical Care for Squamous Cell Carcinoma of the Head and Neck
Clinical trial NCT03325465 · WITHDRAWN
Trial details
- NCT number
- NCT03325465
- Sponsor
- University of Chicago
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-22
- Primary completion
- 2018-11-07
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.